Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React
Propanc Biopharma, Inc. shares jumped Thursday as the company set a $5 million stock buyback plan. Investors saw the buyback as a vote of confidence from management for the beaten-down Nasdaq name. PPCB was last seen at $6.04, up $4.69 from Wednesday’s $1.35 close, after hitting $6.64 earlier on strong volume.